Published on May 14, 2009
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report
of NeoGenomics, Inc. (the “Company”) on Form 10-Q for the three months ended
March 31, 2009 as filed with the Securities and Exchange Commission on the date
hereof (the “Report”), each of the undersigned, in the capacities and on the
dates indicated below, hereby certify pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his
knowledge:
1. The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
2. The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Company.
|
Date:
May 13, 2009
|
/s/ Robert P.
Gasparini
|
|
|
Robert
P. Gasparini
|
||
|
President
and Chief Science Officer
|
||
|
Date:
May 13, 2009
|
/s/ Steven C.
Jones
|
|
|
Steven
C. Jones
|
||
|
Acting
Principal Financial Officer
|
||
|
Date:
May 13, 2009
|
/s/ Jerome J.
Dvonch
|
|
|
Jerome
J. Dvonch
|
||
|
Director
of Finance and Principal Accounting
Officer
|
||
The
foregoing certification is being furnished solely to accompany the Report
pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before or
after the date hereof, regardless of any general incorporation language in such
filing. A signed original of this written statement required by
Section 906, or other document authenticating, acknowledging, or otherwise
adopting the signature that appears in typed form within the electronic version
of this written statement required by Section 906, has been provided to the
Company and will be retained by the Company and furnished to the Securities and
Exchange Commission or its staff upon request.